Concepedia

April Bai

AB

Statistics

Publications

5

Citations

358

H-Index

5

Active since

2011

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

April Bai is an author at Bristol-Myers Squibb (Switzerland) specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2011–2021

5

Publications

5

Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability

Samantha J. Richardson, April Bai, Ashutosh A. Kulkarni et al. · Drug Metabolism Letters · 2016 · 143 citations · Full text

, , +17

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor

Véronique Plantevin Krenitsky, Lisa Nadolny, Mercedes Delgado et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 114 citations · Full text

, , +9

Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator

Sekhar Surapaneni, Usha Yerramilli, April Bai et al. · Drug Metabolism and Disposition · 2021 · 72 citations · Full text

, , +8

Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors

Garrick K. Packard, Patrick Papa, Jennifer R. Riggs et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

, , +12

Proposing Advancement Criteria for Efficient Dmpk Triage of New Chemical Entities

Ashutosh A. Kulkarni, Jennifer Riggs, Cindy Phan et al. · Future Medicinal Chemistry · 2014 · 10 citations

, , +11

1–5 of 5